This bill requires the health insurance commissioner to produce a report focusing on prescription drug prior authorizations by January 1, 2026, as part of the ongoing work of a healthcare administration workgroup that includes representatives from healthcare providers, health insurers, medical societies, and community health organizations. The bill amends an existing law to mandate that this workgroup, which was already tasked with developing guidelines to streamline healthcare administration, specifically create a report examining prescription drug prior authorization processes. The bill gives the commissioner authority to request information and take enforcement actions to ensure workgroup members comply with the reporting requirement. This new reporting mandate builds upon existing efforts to improve healthcare administrative processes, with a specific focus on understanding and potentially improving the prior authorization procedures for prescription medications, which can often create barriers or delays in patient access to needed treatments.